EYA4 and pancreatic ductal adenocarcinoma: Because our previous studies demonstrated that EYA4 dephosphorylates β-catenin Ser675 in human pancreatic ductal adenocarcinoma [22], we explored whether β-catenin Ser675 dephosphorylation is instrumental for RAP1 repression by EYA4 in HCC.